MorphoSys AG (MOR) recorded a wider loss year-on-year in the first quarter due to higher expenses mainly driven by increased R&D, selling and general & administrative expenses. Looking forward, the company reaffirmed its guidance for 2019.
from RTT - Earnings http://bit.ly/2WzLq4A
via IFTTT
No comments:
Post a Comment